Skip to main content
Erschienen in: Intensive Care Medicine 2/2005

01.02.2005 | Editorial

Surviving sepsis—but for how long?

verfasst von: Peter Dodek

Erschienen in: Intensive Care Medicine | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Excerpt

Severe sepsis, defined as infection plus a systemic response and organ dysfunction, hypoperfusion, or hypotension [1], occurs in about 10% of patients who are cared for in intensive care units (ICUs) [2, 3]. In the United States the attributable cost of this condition is nearly $17 billion annually [4]. Severe sepsis is associated with a 28-day mortality that ranges between 20% [5] and 55% [2]. Although most of the deaths due to this condition occur during the first month after presentation, mortality has been estimated to be 45% at 5 months after admission [3], 68% at 6 months [6], and 72% at 1 year [6]. In a cohort study of septic patients who had been screened for a study of corticosteroids in systemic sepsis and a control group of noninfected patients, sepsis was found to be associated with an increased risk of death up to 5 years after the septic episode [7]. In 30-day survivors it was associated with a reduction in median survival from 6.2 to 2.4 years [7]. Furthermore, survivors of sepsis report abnormal physical function and general health [8]. …
Literatur
1.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal S, Vincent J-L, Ramsay G for the International Sepsis Definitions Conference (2003) SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256CrossRefPubMed Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal S, Vincent J-L, Ramsay G for the International Sepsis Definitions Conference (2003) SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256CrossRefPubMed
2.
Zurück zum Zitat Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274:968–974PubMed Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274:968–974PubMed
3.
Zurück zum Zitat Sands KE, Bates DW, Lanken PH, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson Jr BL, Platt R for the Academic Medical Center Consortium Sepsis Project Working Group (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234–240CrossRef Sands KE, Bates DW, Lanken PH, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson Jr BL, Platt R for the Academic Medical Center Consortium Sepsis Project Working Group (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234–240CrossRef
4.
Zurück zum Zitat Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310CrossRefPubMed
5.
Zurück zum Zitat Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123CrossRefPubMed Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123CrossRefPubMed
6.
Zurück zum Zitat Sasse KC, Nauenberg E, Long A, Anton B, Tucker HJ, Hu T-W (1995) Long-term survival after intensive care unit admission with sepsis. Crit Care Med 23:1040–1047CrossRefPubMed Sasse KC, Nauenberg E, Long A, Anton B, Tucker HJ, Hu T-W (1995) Long-term survival after intensive care unit admission with sepsis. Crit Care Med 23:1040–1047CrossRefPubMed
7.
Zurück zum Zitat Quartin AA, Schein RMH, Kett DH, Peduzzi PH for the Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group (1997) Magnitude and duration of the effect of sepsis on survival. JAMA 277:1058–1063PubMed Quartin AA, Schein RMH, Kett DH, Peduzzi PH for the Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group (1997) Magnitude and duration of the effect of sepsis on survival. JAMA 277:1058–1063PubMed
8.
Zurück zum Zitat Perl TM, Dvorak L, Hwang T, Wenzel RP (1995) Long-term survival and function after suspected gram-negative sepsis. JAMA 274:338–345PubMed Perl TM, Dvorak L, Hwang T, Wenzel RP (1995) Long-term survival and function after suspected gram-negative sepsis. JAMA 274:338–345PubMed
9.
Zurück zum Zitat Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S (2001) New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 29:880–886CrossRef Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S (2001) New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 29:880–886CrossRef
10.
Zurück zum Zitat Angus DC, Laterre P-F, Helterbrand J, Ely EW, Ball DE, Garg R, Weissfeld LA, Bernard GR for the PROWESS Investigators (2004) The effect of drotrecogin alfa (activated) on long0-term survival after severe sepsis. Crit Care Med 32:2199–2206 Angus DC, Laterre P-F, Helterbrand J, Ely EW, Ball DE, Garg R, Weissfeld LA, Bernard GR for the PROWESS Investigators (2004) The effect of drotrecogin alfa (activated) on long0-term survival after severe sepsis. Crit Care Med 32:2199–2206
12.
Zurück zum Zitat Kasal J, Jovanovic Z, Clermont G, Weissfeld LA, Kaplan V, Watson RS, Angus DC (2004) Comparison of Cox and Gray’s survival models in severe sepsis. Crit Care Med 32:700–707CrossRef Kasal J, Jovanovic Z, Clermont G, Weissfeld LA, Kaplan V, Watson RS, Angus DC (2004) Comparison of Cox and Gray’s survival models in severe sepsis. Crit Care Med 32:700–707CrossRef
13.
Zurück zum Zitat Dellinger RP, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent J-L, Levy MM for the Surviving Sepsis Campaign Management Guidelines Committee (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873CrossRefPubMed Dellinger RP, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent J-L, Levy MM for the Surviving Sepsis Campaign Management Guidelines Committee (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873CrossRefPubMed
14.
Zurück zum Zitat Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O’Brien MA (2001) Changing provider behavior: an overview of systematic reviews of interventions. Med Care 39:II-2–II-45CrossRef Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O’Brien MA (2001) Changing provider behavior: an overview of systematic reviews of interventions. Med Care 39:II-2–II-45CrossRef
15.
Zurück zum Zitat Weeks WB, Mills PD, Dittus RS, Aron DC, Batalden PB (2001) Using an improvement model to reduce adverse drug events in VA facilities. Joint Comm J Qual Imp 27:243–254 Weeks WB, Mills PD, Dittus RS, Aron DC, Batalden PB (2001) Using an improvement model to reduce adverse drug events in VA facilities. Joint Comm J Qual Imp 27:243–254
16.
Zurück zum Zitat Langley GJ, Nolan KM, Nolan TW, Norman CL, Provost LP (1996) The improvement guide: a practical approach to enhancing organizational performance. Jossey-Bass, San Francisco Langley GJ, Nolan KM, Nolan TW, Norman CL, Provost LP (1996) The improvement guide: a practical approach to enhancing organizational performance. Jossey-Bass, San Francisco
Metadaten
Titel
Surviving sepsis—but for how long?
verfasst von
Peter Dodek
Publikationsdatum
01.02.2005
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 2/2005
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-004-2546-4

Weitere Artikel der Ausgabe 2/2005

Intensive Care Medicine 2/2005 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.